Clinical Trial Update: CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 1/2 study evaluating valproic acid and carnitine in infants with spinal muscular atrophy, with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• L-carnitine (L-carnitine)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: University of Utah | Conditions: Spinal Muscular Atrophy Type I | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-06-15